The Landscape of Candidemia During the Coronavirus Disease 2019 (COVID-19) Pandemic
Clinical Infectious Diseases2021Vol. 74(5), pp. 802–811
Citations Over TimeTop 10% of 2021 papers
Emma E. Seagle, Brendan R. Jackson, Shawn R. Lockhart, Ourania Georgacopoulos, Natalie S. Nunnally, Jeremy Roland, Devra M. Barter, Helen Johnston, Christopher A. Czaja, Hazal Kayalioglu, Paula Clogher, Andrew Revis, Monica M. Farley, Lee H. Harrison, Sarah Shrum Davis, Erin C. Phipps, Brenda L. Tesini, William Schaffner, Tiffanie Markus, Meghan Lyman
Abstract
One-quarter of candidemia patients had COVID-19. These patients were less likely to have certain underlying conditions and recent surgery commonly associated with candidemia and more likely to have acute risk factors linked to COVID-19 care, including immunosuppressive medications. Given the high mortality, it is important for clinicians to remain vigilant and take proactive measures to prevent candidemia in patients with COVID-19.
Related Papers
- → Evaluation of predicted and actual length of stay in 22 Scottish intensive care units using the APACHE III system(2000)36 cited
- → Appropriate antibiotic administration in critically ill patients with pneumonia(2015)10 cited
- → Nosocomial Pneumonia Outside the Intensive Care Unit(2011)4 cited
- → Recognition of Nosocomial Pneumonia in the Intensive Care Unit: Still a Confusing Issue(2011)3 cited
- [Risk factors of prolonged intensive care after early activation of cardiosurgical patients].(2008)